These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7843265)

  • 41. CoMFA study of novel phenyl ring-substituted 3alpha-(diphenylmethoxy)tropane analogues at the dopamine transporter.
    Newman AH; Izenwasser S; Robarge MJ; Kline RH
    J Med Chem; 1999 Sep; 42(18):3502-9. PubMed ID: 10479283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.
    Reith ME; Berfield JL; Wang LC; Ferrer JV; Javitch JA
    J Biol Chem; 2001 Aug; 276(31):29012-8. PubMed ID: 11395483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly potent cocaine analogs cause long-lasting increases in locomotor activity.
    Fleckenstein AE; Kopajtic TA; Boja JW; Carroll FI; Kuhar MJ
    Eur J Pharmacol; 1996 Sep; 311(2-3):109-14. PubMed ID: 8891589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey.
    Farfel GM; Kleven MS; Woolverton WL; Seiden LS; Perry BD
    Brain Res; 1992 Apr; 578(1-2):235-43. PubMed ID: 1380862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding domains for blockers and substrates on the dopamine transporter in rat striatal membranes studied by protection against N-ethylmaleimide-induced reduction of [3H]WIN 35,428 binding.
    Xu C; Coffey LL; Reith ME
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):64-73. PubMed ID: 9007844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.
    Ghorai SK; Cook C; Davis M; Venkataraman SK; George C; Beardsley PM; Reith ME; Dutta AK
    J Med Chem; 2003 Mar; 46(7):1220-8. PubMed ID: 12646032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
    Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
    Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationships for substrate recognition by the human dopamine transporter.
    Appell M; Berfield JL; Wang LC; Dunn WJ; Chen N; Reith ME
    Biochem Pharmacol; 2004 Jan; 67(2):293-302. PubMed ID: 14698042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane.
    Madras BK; Spealman RD; Fahey MA; Neumeyer JL; Saha JK; Milius RA
    Mol Pharmacol; 1989 Oct; 36(4):518-24. PubMed ID: 2811854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.
    Lin Z; Wang W; Kopajtic T; Revay RS; Uhl GR
    Mol Pharmacol; 1999 Aug; 56(2):434-47. PubMed ID: 10419565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a recombinant human dopamine transporter in multiple cell lines.
    Eshleman AJ; Neve RL; Janowsky A; Neve KA
    J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration.
    Wilson JM; Nobrega JN; Carroll ME; Niznik HB; Shannak K; Lac ST; Pristupa ZB; Dixon LM; Kish SJ
    J Neurosci; 1994 May; 14(5 Pt 2):2966-79. PubMed ID: 8182452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Syntheses of 3-carbomethoxy-4-(aryl)piperidines and in vitro and in vivo pharmacological evaluation: identification of inhibitors of the human dopamine transporter.
    Feng X; Fandrick K; Johnson R; Janowsky A; Cashman JR
    Bioorg Med Chem; 2003 Mar; 11(5):775-80. PubMed ID: 12538008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and ligand binding of eta(6)-(2beta-carbomethoxy-3beta-phenyltropane) transition metal complexes.
    Aronson B; Enmon JL; Izenwasser S; Katz JL; Kelkar SV; Luo L; Nolan SP; Trudell ML
    J Med Chem; 1996 Mar; 39(7):1560-3. PubMed ID: 8691489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2'-substituted analogs of cocaine: synthesis and dopamine transporter binding potencies.
    el-Moselhy TF; Avor KS; Basmadjian GP
    Arch Pharm (Weinheim); 2001 Sep; 334(8-9):275-8. PubMed ID: 11688137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of a novel dopamine transporter inhibitor, 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships, and behavioral pharmacological studies.
    Wang S; Sakamuri S; Enyedy IJ; Kozikowski AP; Deschaux O; Bandyopadhyay BC; Tella SR; Zaman WA; Johnson KM
    J Med Chem; 2000 Feb; 43(3):351-60. PubMed ID: 10669562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
    Matecka D; Lewis D; Rothman RB; Dersch CM; Wojnicki FH; Glowa JR; DeVries AC; Pert A; Rice KC
    J Med Chem; 1997 Feb; 40(5):705-16. PubMed ID: 9057857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
    Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
    Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.
    Houlihan WJ; Boja JW; Parrino VA; Kopajtic TA; Kuhar MJ
    J Med Chem; 1996 Dec; 39(25):4935-41. PubMed ID: 8960553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.